- Media & Publications
Brussels, 18 February - Effective 20 December 2013, the California Office of Environmental Health Hazard Assessment (Cal. OEHHA) added DINP to the list of chemicals known to the State of California to cause cancer.
Contrary to the listing in the US, the official EU Risk assessment, where the full toxicological data have been evaluated, concluded that the data do not warrant a cancer classification as the results identified in the rodent (rats and mice) studies with DINP are not relevant to humans.
Brussels 16, February - Denmark has recently communicated to the European Chemicals Agency (ECHA) its intention to submit a dossier for the harmonised classification and labelling (CLH) of di-isononyl phthalate (DINP) as toxic to reproduction - Category 1B (Development) and Category 2 (Fertility). This is a classification proposal under the CLP (Classification, Labelling and Packaging) regulation and the dossier has to be submitted before a public consultation and review process can start. However, regardless the issue mentioned above, DINP can continue to be safely used in all current applications, as was confirmed by the re-evaluation conducted by ECHA, the European Commission and Member States in January 2014 (“no further risks identified”).
There is an increasing number of publications describing associations of clinical symptoms like reduced sperm counts, asthma, obesity and diabetes type II and phthalate exposure.
ECPI has initiated a project that intends to investigate whether the studies published do meet the basic quality requirements as outlined in the STROBE criteria for epidemiological studies.
It is with deep concern that ECPI notes the ECHA Member State Committee has concluded that DEHP is an endocrine disruptor of equivalent level of concern for its environmental properties. The science on DEHP does not support such a conclusion as the weight of evidence shows that DEHP does not cause adverse endocrine effects in fish and other aquatic organisms. This was also the reason for non-classification for environmental hazards in the conclusion of the EU DEHP RAR (Risk Assessment Report) which at the time had been agreed by all member states. In addition, lack of reproductive effects in primates and species differences for rat, mouse and humans is not in agreement with a concern for mammals in the environment. Moreover, DEHP does not bio accumulate and therefore DEHP cannot pose a hazard to higher mammals in the environment. ECPI does not agree with the Member State Committee that the WHO/IPCS definition of adverse effects consequent to an endocrine mode of action, for the environment, has been met and demonstrated in the dossiers submitted. “We can only conclude that the decision has been political rather than science based” stated Dr. Stephane Content of ECPI.
Brussels, 10 December 2014: Representatives from the entire flexible PVC value chain met this week at the Plasticisers Conference 2014 to discuss the latest developments in the sector.Participants agreed on the need for improved coordination amongst EU and national regulators to guarantee a competitive and cost effective level playing field for the entire chemical industry.